Anti-mag neuropathy

Clinical trials for Anti-mag neuropathy explained in plain language.

Never miss a new study

Get alerted when new Anti-mag neuropathy trials appear

Sign up with your email to follow new studies for Anti-mag neuropathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Nerve signal test may forecast treatment success in rare nerve disease

Diagnosis Not yet recruiting

Anti-MAG neuropathy is a rare nerve condition that can cause disability, and treatments like rituximab or IVIg work differently for each person. Researchers are studying whether a simple nerve test, the Terminal Latency Index (TLI), can predict who will respond well to treatment.…

Matched conditions: ANTI-MAG NEUROPATHY

Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis

Last updated Sep 02, 2026 00:00 UTC

Anti-mag neuropathy

Get alerted when new Anti-mag neuropathy trials appear

Nerve signal test may forecast treatment success in rare nerve disease